Eva M. Sevick-Muraca
Cancer Research · 2013
A researcher in the Science corpus: 1 paper; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Eva M. Sevick-Muraca trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Eva M. Sevick-Muraca's perspective
Ordered by how strongly the researchers Eva M. Sevick-Muraca trusts endorse each paper. Same corpus, a different order for every researcher.
- Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. (Journal of Clinical Oncology)
- Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile (Science Translational Medicine)
- Delivering nanomedicine to solid tumors (Nature Reviews Clinical Oncology)
- Pathology: Cancer cells compress intratumour vessels (Nature)
- Role of extracellular matrix assembly in interstitial transport in solid tumors. (Cancer Research)
- Tissue-penetrating delivery of compounds and nanoparticles into tumors (Cancer Cell)
- The effect of particle design on cellular internalization pathways (Proceedings of the National Academy of Sciences of the United States of America)
- Nanoparticle-mediated cellular response is size-dependent. (Nature Nanotechnology)
- Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors (Proceedings of the National Academy of Sciences of the United States of America)
- Angiogenesis in life, disease and medicine (Nature)